Literature DB >> 6672794

Bovine intermediate pituitary alpha-amidation enzyme: preliminary characterization.

B A Eipper, C C Glembotski, R E Mains.   

Abstract

A secretory granule-associated enzymatic activity that converts mono-[125I]-D-Tyr-Val-Gly into mono-[125I]-D-Tyr-Val-NH2 has been studied. The activity is primarily soluble and shows optimal activity at pH 7 to pH 8. Amidation activity was stimulated 9-fold by addition of optimal amounts of copper (3 microM). In the presence of optimal copper, ascorbate stimulated the reaction 7-fold; none of the other reduced or oxidized cofactors tested was as effective. Taking into account the dependence of the reaction on ascorbate and molecular oxygen and the production of glyoxylate [2], it is suggested that the alpha-amidation enzyme is a monooxygenase. Lineweaver Burk plots with D-Tyr-Val-Gly as the varied substrate demonstrated Michelis-Menten type kinetics with the values of Km and Vmax increasing with the addition of ascorbate to the assay. A variety of peptides ending with a COOH-terminal Gly residue act as inhibitors of the reaction. Two synthetic peptides, gamma 2MSH and ACTH(1-14), with carboxyl termini similar to the presumed physiological substrates for the enzyme, act as competitive inhibitors with similar K1 values. It is likely that this secretory granule alpha-amidation activity is involved in the physiological biosynthetic alpha-amidation of a wide range of bioactive peptides.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6672794     DOI: 10.1016/0196-9781(83)90091-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

1.  Evidence for high peptide alpha-amidating activity in the pancrease from neonatal rats.

Authors:  L Ouafik; P Giraud; P Salers; A Dutour; E Castanas; F Boudouresque; C Oliver
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

2.  Early eukaryotic origins for cilia-associated bioactive peptide-amidating activity.

Authors:  Dhivya Kumar; Crysten E Blaby-Haas; Sabeeha S Merchant; Richard E Mains; Stephen M King; Betty A Eipper
Journal:  J Cell Sci       Date:  2016-01-19       Impact factor: 5.285

3.  Transport of ascorbic acid and dehydroascorbic acid by pancreatic islet cells from neonatal rats.

Authors:  A Zhou; J H Nielsen; O Farver; N A Thorn
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

4.  Evidence for presence of peptide alpha-amidating activity in pancreatic islets from newborn rats.

Authors:  A Zhou; N A Thorn
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

5.  Haploinsufficiency in peptidylglycine alpha-amidating monooxygenase leads to altered synaptic transmission in the amygdala and impaired emotional responses.

Authors:  Eric D Gaier; Ramona M Rodriguiz; Xin-Ming M Ma; Shobhana Sivaramakrishnan; Danielle Bousquet-Moore; William C Wetsel; Betty A Eipper; Richard E Mains
Journal:  J Neurosci       Date:  2010-10-13       Impact factor: 6.167

6.  Exocrine secretion granules contain peptide amidation activity.

Authors:  M von Zastrow; T R Tritton; J D Castle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  Reversal of physiological deficits caused by diminished levels of peptidylglycine alpha-amidating monooxygenase by dietary copper.

Authors:  D Bousquet-Moore; X M Ma; E A Nillni; T A Czyzyk; J E Pintar; B A Eipper; R E Mains
Journal:  Endocrinology       Date:  2008-11-20       Impact factor: 4.736

8.  Genetic determinants of amidating enzyme activity and its relationship with metal cofactors in human serum.

Authors:  Eric D Gaier; Alison Kleppinger; Martina Ralle; Jonathan Covault; Richard E Mains; Anne M Kenny; Betty A Eipper
Journal:  BMC Endocr Disord       Date:  2014-07-15       Impact factor: 2.763

9.  The Length of the Expressed 3' UTR Is an Intermediate Molecular Phenotype Linking Genetic Variants to Complex Diseases.

Authors:  Elisa Mariella; Federico Marotta; Elena Grassi; Stefano Gilotto; Paolo Provero
Journal:  Front Genet       Date:  2019-08-16       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.